1. Uehara S, Murayama N, Higuchi Y, Yoneda N, Yamazaki H and Suemizu H. Comparison of mouse and human cytochrome P450 mediated-drug metabolising activities in hepatic and extrahepatic microsomes. Xenobiotica. 2022, 1-11, doi:10.1080/00498254.2022.2066581
2. Uehara S, Shimizu M, Ple K, Routier S, Yoneda N, Higuchi Y, Suemizu H and Yamazaki H. Probe drug T-1032 N-oxygenation mediated by cytochrome P450 3A5 in human hepatocytes in vitro and in humanized-liver mice in vivo. Drug Metab Pharmacokinet. 2022, 44, 100453, doi:10.1016/j.dmpk.2022.100453
3. Uehara S, Yoneda N, Higuchi Y, Yamazaki H and Suemizu H. Cytochrome P450-dependent drug oxidation activities and their expression levels in liver microsomes of chimeric TK-NOG mice with humanized livers. Drug Metab Pharmacokinet. 2022, 44, 100454, doi:10.1016/j.dmpk.2022.100454
4. Uehara S, Higuchi Y, Yoneda N, Kawai K, Yamamoto M, Kamimura H, Iida Y, Oshimura M, Kazuki Y, Yamazaki H, Hikita H, Takehara T and Suemizu H. An improved TK-NOG mouse as a novel platform for humanized liver that overcomes limitations in both male and female animals. Drug Metab Pharmacokinet. 2022, 42, 100410, doi:10.1016/j.dmpk.2021.100410
5. Miura T, Uehara S, Shimizu M, Murayama N, Suemizu H and Yamazaki H. Roles of human cytochrome P450 1A2 in coumarin 3,4-epoxidation mediated by untreated hepatocytes and by those metabolically inactivated with furafylline in previously transplanted chimeric mice. J Toxicol Sci. 2021, 46, 525-530, doi:10.2131/jts.46.525
6. Uehara S, Yoneda N, Higuchi Y, Yamazaki H and Suemizu H. Oxidative metabolism and pharmacokinetics of the EGFR inhibitor BIBX1382 in chimeric NOG-TKm30 mice transplanted with human hepatocytes. Drug Metab Pharmacokinet. 2021, 41, 100419, doi:10.1016/j.dmpk.2021.100419
7. Uehara S, Higuchi Y, Yoneda N, Yamazaki H and Suemizu H. UDP-glucuronosyltransferase 1A4-mediated N2-glucuronidation is the major metabolic pathway of lamotrigine in chimeric NOG-TKm30 mice with humanised-livers. Xenobiotica. 2021, 51, 1146-1154, doi:10.1080/00498254.2021.1972492
8. Miura T, Uehara S, Shimizu M, Suemizu H and Yamazaki H. Pharmacokinetics of primary oxidative metabolites of thalidomide in rats and in chimeric mice humanized with different human hepatocytes. J Toxicol Sci. 2021, 46, 311-317, doi:10.2131/jts.46.311
9. Matsumoto S, Uehara S, Kamimura H, Ikeda H, Maeda S, Hattori M, Nishiwaki M, Kato K and Yamazaki H. Human total clearance values and volumes of distribution of typical human cytochrome P450 2C9/19 substrates predicted by single-species allometric scaling using pharmacokinetic data sets from common marmosets genotyped for P450 2C19. Xenobiotica. 2021, 51, 479-493, doi:10.1080/00498254.2020.1871113